Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-641


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 340, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
MRPL17 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr11:6681943-6681970 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EYA3 hsa-miR-641 low: 0 high: 1 1 1 1 0.648
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:27971065-27971089 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DZIP1L hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr3:138062724-138062749 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ELK4 hsa-miR-641 low: 0 high: 1 1 1 1 0.731
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:205610298-205610315 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SON hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr21:33577405-33577427 HITS-CLIP POSITIVE DIRECT TarBase 7.0
UBE2Z hsa-miR-641 low: 0 high: 1 1 1 1 0.889
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr17:48928958-48928977 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PDXK hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr21:43756442-43756470 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF714 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:21117700-21117724 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TAOK1 hsa-miR-641 low: 0 high: 1 1 1 1 0.839
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr17:29547598-29547621 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SQSTM1 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr5:179822921-179822945 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CMPK1 hsa-miR-641 low: 0 high: 1 1 1 1 0.534
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:47378054-47378077 HITS-CLIP POSITIVE DIRECT TarBase 7.0
USP1 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:62451570-62451598 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLC30A7 hsa-miR-641 low: 0 high: 1 1 1 1 0.916
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:100981672-100981693 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SGPP2 hsa-miR-641 low: 0 high: 1 1 1 1 0.455
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:222521784-222521804 HITS-CLIP POSITIVE DIRECT TarBase 7.0
LRRC58 hsa-miR-641 low: 0 high: 1 1 1 1 0.457
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:120328849-120328877 PAR-CLIP POSITIVE DIRECT TarBase 7.0
FSTL1 hsa-miR-641 low: 0 high: 1 1 1 1 0.550
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:120394461-120394484 HITS-CLIP POSITIVE DIRECT TarBase 7.0
STT3B hsa-miR-641 low: 0 high: 1 1 1 1 0.654
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:31619725-31619744 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ATXN7 hsa-miR-641 low: 0 high: 1 1 1 1 0.594
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr3:64002159-64002180 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DTX3L hsa-miR-641 low: 0 high: 1 1 1 1 0.525
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr3:122574443-122574454 HITS-CLIP POSITIVE DIRECT TarBase 7.0
WDR82 hsa-miR-641 low: 0 high: 1 1 1 1 0.514
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr3:52257040-52257058 HITS-CLIP POSITIVE DIRECT TarBase 7.0